From: Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study
Category in PDQ-8
(n = 2422)
Mobility
2.1 ± 1.3
Activities of daily living
2.0 ± 1.2
Emotional well being
1.8 ± 1.1
Social support
1.0 ± 1.2
Cognitions
1.5 ± 1.1
Communication
1.4 ± 1.2
Bodily discomfort
Stigma
1.1 ± 1.1